When the 2-year-old son of Israeli Ilan Ganot was diagnosed with Duchenne muscular dystrophy, an incurable degenerative disease, the former hedge fund specialist decided he had a role to play in finding a cure. So he used his finance and investment clout to set up a company for developing treatments – and raised $17 million so it could get to work.